Guided navigator
Turn confusing oncology information into better questions.
This tool does not recommend treatment. It matches your answers to source-linked records, trial search words, guides, and patient or parent stories.
Navigator output
Start with these 3 questions
This is not a treatment recommendation. It gives you questions to bring to your next visit.
- Is nivolumab being discussed alone or with another immunotherapy?
- Is this before surgery, after surgery, or for unresectable/metastatic disease?
- How does prior PD-1 exposure change later options?
Visit prep
One-page summary for the next visit
This pulls the selected situation, key questions, trial search words, and related source records into one place.
Situation
melanoma · stage not sure · NRAS · United States
Prior treatments: PD-1 / PD-L1 therapy
Questions to bring
- Is nivolumab being discussed alone or with another immunotherapy?
- Is this before surgery, after surgery, or for unresectable/metastatic disease?
- How does prior PD-1 exposure change later options?
Trial search words
- melanoma clinical trial
- NRAS melanoma clinical trial
- NRAS melanoma MEK inhibitor
- melanoma after PD-1 failure
Related source records
- Nivolumab
- Pembrolizumab
- NRAS-mutant melanoma
What we know, what is unclear, what to ask
- A trial listing is only a lead. The trial team must confirm whether it fits.
- A medicine may be available in one country but not another.
- Use this as a question list for your doctors, not as instructions.